Rosalind Advisors, Inc.

Q4 2025 13F-HR Holdings

Location
Toronto, A6
Holdings as of
12/31/2025
Date filed
2/12/2026
Form type
13F-HR
Num holdings
42
Total value ($000)
$284,527
Net value change ($000)
-8,036 (-2.7%)
New positions
5
Sold out positions
5
Turnover %
25.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q3 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
REPL 13,710 NEW
SVRA 6,244 43.7%
ATYR 6,037 79.8%
XFOR 5,141 97.3%
PROF 5,028 148.5%
HELP 4,724 53.5%
AVBP 4,343 NEW
EYPT 3,350 36.2%
OKUR 2,118 NEW
XERS 1,959 13.4%
Top Reduces (Value $000, Stocks/ETFs)
RZLT -16,988 -100.0%
VRNA -10,671 -100.0%
CYTK -9,591 -43.6%
IDYA -9,524 -100.0%
QURE -7,296 -100.0%
GUTS -7,101 -89.3%
VSTM -3,231 -19.0%
NSPR -2,461 -26.1%
Astria Therapeutics, Inc. -1,113 -100.0%
BFRI -474 -42.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 10,065 (3.5% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type